Uso degli antibiotici nel fine vita

Documento Intersocietario SICP - SIMIT - FADOI - SIMG

Published: 16 May 2024
Abstract Views: 516
PDF: 649
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Introduzione

Survey intersocietaria SICP-SIMIT-FADOI-SIMG

La febbre in un contesto clinico di fine vita

Peculiarità dei principali setting di cura

Principali quadri sindromici nei pazienti a fine vita e indicazioni terapeutiche

Antibiotici in infusione continua endovena o per via sottocutanea

Bibliografia

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Schneiderman LJ. Defining medical futility and improving medical care. J Bioeth Inq 2011;8:123-31. DOI: https://doi.org/10.1007/s11673-011-9293-3
Schneiderman LJ, Jecker NS, Jonsen AR. Medical futility: its meaning and ethical implications. Ann Intern Med 1990;112:949-54. DOI: https://doi.org/10.7326/0003-4819-112-12-949
Jecker NS, Schneiderman LJ. Futility and rationing. Am J Med 1992;92:189-96. DOI: https://doi.org/10.1016/0002-9343(92)90111-N
McMillan J. Futility: a perennial issue for medical ethics. J Med Ethics 2021;47:649. DOI: https://doi.org/10.1136/medethics-2021-107866
Jox RJ, Schaider A, Marckmann G, Borasio GD. Medical futility at the end of life: the perspectives of intensive care and palliative care clinicians. J Med Ethics 2012;38:540-5. DOI: https://doi.org/10.1136/medethics-2011-100479
Kopar PK, Visani A, Kyler Squirrell K, Brown DE. Addressing futility: a practical approach. Crit Care Explor 2022;4:e0706. DOI: https://doi.org/10.1097/CCE.0000000000000706
Mori M, Morita T, Bruera E, Hui D. Prognostication of the Last Days of Life. Cancer Res Treat 2022;54:631-43. DOI: https://doi.org/10.4143/crt.2021.1573
Hosoi T, Ozone S, Hamano J, et al. Prediction models for impending death using physical signs and vital signs in noncancer patients: a prospective longitudinal observational study. Palliat Med Rep 2021;2:287-95. DOI: https://doi.org/10.1089/pmr.2021.0029
Hui D, Hess K, dos Santos R, et al. A diagnostic model for impending death in cancer patients: Preliminary report. Cancer 2015;121:3914-21. DOI: https://doi.org/10.1002/cncr.29602
Hosoi T, Sachiko Ozone S, Hamano J. Variations in vital signs at the end of life in non-cancer patients: a retrospective study Ann Palliat Med 2020;9:2678-83. DOI: https://doi.org/10.21037/apm-20-1054
Chen LK, Yu-Ching C, Hsu PS, et al. Antibiotic prescription for fever episodes in hospice patients. Supp Care Cancer 2002;10:538-41. DOI: https://doi.org/10.1007/s00520-002-0377-9
Carbone M, Gilioli F, Antonione R. Le cure palliative nel malato internistico: focus sulle malattie croniche in fase avanzata. FADOI Quaderni Ital J Med 2022. DOI: https://doi.org/10.4081/itjm.q.2022.5
Rhodes RL, Tindall K, Xuan L, et al. Communication about advance directives and end-of-life care options among internal medicine residents. Am J Hosp Palliat Care 2015;32:262-68. DOI: https://doi.org/10.1177/1049909113517163
Oluyase AO, Higginson IJ, Yi D, et al. Hospital-based specialist palliative care compared with usual care for adults with advanced illness and their caregivers: a systematic review. Southampton (UK): NIHR Journals Library; 2021. DOI: https://doi.org/10.3310/hsdr09120
Vaughan L, Duckett AA, Adler M, Cain J. Ethical and clinical considerations in treating infections at the end of life. J Hospice Palliat Nurs 2019;21:110-5. DOI: https://doi.org/10.1097/NJH.0000000000000541
NHS. Infection management Guidelines Empirical Antibiotic Therapy in Adult. NHS 2020. Disponibile da: https://handbook.ggcmedicines.org.uk/media/1133/2021-infection-management-poster.pdf
NHS. Infection Management in Adults, Primary Care. NHSGGC, 2022. Disponibile da: https://rightdecisions.scot.nhs.uk/media/2583/166-inf-mng-adults-fp.pdf
Abdel-Karim IA, Sammel RB, Prange MA. Causes of death at autopsy in an inpatient hospice program. J Palliat Med 2007;10:894-8. DOI: https://doi.org/10.1089/jpm.2006.0240
Odagiri T, Maeda I, Mori M, et al. Effects of antibiotics on respiratory symptoms in terminally ill cancer patients with pneumonia: a multicenter cohort study. Am J Hosp Palliat Care 2022;39:1082-9. DOI: https://doi.org/10.1177/10499091211058156
Mermel LA, Allon M, Bouza E, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 up-date by the Infectious Diseases Society of America. Clin Infect Dis 2009;49:1-45. DOI: https://doi.org/10.1086/599376
Bouza E, Garnacho-Montero J, del Pozo JL, et al. Diagnosis and treatment of catheter-related bloodstream infection: clinical guidelines of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC). Med Intensiva 2018;42:5-36. DOI: https://doi.org/10.1016/j.medin.2017.09.012
Calderwood MS. Intravascular non-hemodialysis catheter-related infection: treatment. UpToDate Jun 28, 2023. Disponibile da: https://www.uptodate.com/contents/intravascular-non-hemodialysis-catheter-related-infectiontreatment
Farmer ECW, Seaton RA. Recent innovations a new applications of outpatient parenteral antimicrobial therapy. Expert Rev Anti Infect Ther 2021;19:55-64. DOI: https://doi.org/10.1080/14787210.2020.1810566
Azienda Regionale di Coordinamento per la Salute Regione Autonoma Friuli Venezia Giulia; Rete Cure Sicure FVG - Direzione centrale salute, politiche sociali e disabilità. Raccomandazioni per la gestione dei sistemi elastomerici di infusione. Versione 0 del 07/12/2018. Disponibile da: https://arcs.sanita.fvg.it/media/uploads/2020/05/15/Raccomandazioni%20per%20la%20gestione%20dei%20sistemi%20elastomerici%20di%20infusione.pdf
Samad EL, Y, Lanoix JP, Bennis Y et al. Tolerability and plasma drug level monitoring of prolonged subcutaneous teicoplanin treatment for bone and joint infections. Antimicrob Ag Chemother 2016;60:6365-8. DOI: https://doi.org/10.1128/AAC.00351-16
Colin E, Baldolli A, Verdon R, et al. Subcutaneously administered antibiotics. Med Mal Infect 2020;50:231-42. DOI: https://doi.org/10.1016/j.medmal.2019.06.007
Jumpertz M, Guilhaumou R, Million M, et al. Subcutaneously administered antibiotics: a review. J Antimicrob Chemother 2022;78:1-7. DOI: https://doi.org/10.1093/jac/dkac383

How to Cite

Moroni, M., Melo, M., Antonione, R., Fantoni, M., Luzzati, R., Lanzafame, M., Murri, R., Gilioli, F., Dentali, F., Manfellotto, D., Fraccaro, B., & Patil, L. (2024). Uso degli antibiotici nel fine vita: Documento Intersocietario SICP - SIMIT - FADOI - SIMG. Italian Journal of Medicine, 12(Quaderni 2024). https://doi.org/10.4081/itjm.q.2024.3